SDZ 64-412 is a novel antiasthmatic agent, a PAF receptor antagonist. References: Charnick SB, Yu Z, Athill LV, Karara AH, Tse FL, Lau DT. Pharmacokinetics of SDZ 64-412, a novel antiasthmatic agent, following intravenous, oral, and inhalation dosing in the rat. Biopharm Drug Dispos. 1994 May;15(4):317-27. PubMed PMID: 8068869.

纯度：≥98%

CAS：115621-84-6